Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences

被引:0
作者
Nielsen, Rene Ernst [1 ]
Nielsen, Jimmi [1 ]
机构
[1] Aarhus Univ Hosp, Aalborg Psychiat Hosp, Unit Psychiat Res, Aalborg, Denmark
来源
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS | 2009年 / 1卷
关键词
schizophrenia; treatment; antipsychotic; atypical; interaction;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cornerstone in treatment of psychosis is antipsychotic drugs. Treatment options have increased over the years; newer antipsychotic drugs with a proposed increased efficacy regarding negative and cognitive symptoms, but also a shift in side-effects from neurological side-effects to metabolic side-effects have arisen as the new challenge. The basis of successful pharmacological treatment is a fundamental understanding of the mechanisms of action, the desired effects and side-effects of antipsychotic drugs, a good relationship with the patient and a thorough monitoring of the patient before and during treatment. The clinically relevant aspects of antipsychotic drug treatment are reviewed; mechanism of antipsychotic drug action, clinical considerations in treatment, switching antipsychotic drugs, polypharmacy, safety and patient preference.
引用
收藏
页码:1053 / 1068
页数:16
相关论文
共 159 条
[1]   SPECIFICITY OF THE CALGARY-DEPRESSION-SCALE FOR SCHIZOPHRENICS [J].
ADDINGTON, D ;
ADDINGTON, J ;
MATICKATYNDALE, E .
SCHIZOPHRENIA RESEARCH, 1994, 11 (03) :239-244
[2]  
Agid O, 2006, J PSYCHIATR NEUROSCI, V31, P93
[3]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[5]  
Ananth J, 2004, J CLIN PSYCHIAT, V65, P464
[6]   Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial [J].
Assion, H. -J. ;
Reinbold, H. ;
Lemanski, S. ;
Basilowski, M. ;
Juckel, G. .
PHARMACOPSYCHIATRY, 2008, 41 (01) :24-28
[7]  
Association AP Letter Outline Adverse Events, 2005, PSYCHIAT NEWS, V40, P66
[8]   Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland [J].
Atkin, K ;
Kendall, F ;
Gould, D ;
Freeman, H ;
Lieberman, J ;
OSullivan, D .
BRITISH JOURNAL OF PSYCHIATRY, 1996, 169 (04) :483-488
[9]  
BALDESSARINI RJ, 1988, ARCH GEN PSYCHIAT, V45, P79
[10]   Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis [J].
Barker, MJ ;
Greenwood, KM ;
Jackson, M ;
Crowe, SF .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2004, 19 (03) :437-454